For the first time, a medicine aimed directly at the HER2 protein improved overall survival after gastric cancer progressed ...

Positive new data suggests that more people facing advanced breast cancer may be able to put off treatment with harsh ...

Adding Enhertu to Perjeta improved time without cancer growth versus standard care in advanced HER2-positive breast cancer, ...

Herceptin (trastuzumab) is a prescription drug that’s used to treat certain types of breast cancer and stomach cancer. Herceptin can cause side effects that range from mild to serious.

You also can use them along with chemo or other treatments. Herceptin (trastuzumab) is one of these targeted medicines for breast cancer. It works against a protein called HER2 (also sometimes ...

Patients were randomly assigned, in a 1:1 ratio, to receive placebo plus trastuzumab (Herceptin, F. Hoffmann–La Roche/Genentech) plus docetaxel or pertuzumab (F. Hoffmann–La Roche/Genentech ...

Authors of the study, published in the cancer journal, Annals of Oncology on August 10, looked at records for 45 women aged between 70 and 92 who had been treated with trastuzumab since 2005 and ...

(MENAFN- GlobeNewsWire - Nasdaq) Dublin, Oct. 22, 2021 (GLOBE NEWSWIRE) -- The "Herceptin (Trastuzumab) Biosimilars: Focus on Approved & Launched Biosimilars ...

13, 2018 /CNW/ - Hoffmann-La Roche Limited (Roche Canada) announced today that Health Canada has approved a subcutaneous formulation of HERCEPTIN for the treatment of early and metastatic stage ...

Using Medicare claims, we documented US prescribing patterns for originator biologic trastuzumab (Herceptin), a targeted cancer therapy, and five biosimilar entrants since 2019. The first ...

Trastuzumab Challenged Claim Types in IPR and Litigation: Claims include those challenged in litigations and IPRs. Claims are counted in each litigation and IPR, so claims from the same patent ...